Ravinderjit Braich
- T. 617.439.2302
- F. 617.310.9000
- E. rbraich@nutter.com
- Download full bio
Overview
Ravinderjit Braich, Ph.D., is an of counsel in Nutter’s Intellectual Property Department. A chemist by training, Ravi advises hospitals, research institutes, universities, corporations, and small and mid-sized life sciences companies on protecting innovative technologies in the United States and abroad. His practice covers patent preparation and prosecution, patent portfolio development and management, patentability and freedom-to-operate opinions, and competitive intelligence and analysis.
Ravi’s technical experience spans the chemical, pharmaceutical, biotechnology, therapeutics, and diagnostic spaces. He has counseled clients on small molecules, nucleic acid-based technologies including RNAi, activating RNAs, antisense nucleic acids, and microRNAs, peptides, antibodies, prodrugs and drug conjugates, anesthetics, antiviral agents, cancer vaccines, and diagnostic and imaging agents. His device work includes drug targeting and drug delivery platforms, microfluidic devices, drug delivery devices, diagnostic devices, and biomimetic devices, along with the synthesis, purification, and use of the underlying compositions.
Clients rely on Ravi to align patent strategy with commercial objectives. He works closely with in-house teams, technology transfer offices, and licensee counsel to position core platform technologies for financing and partnering and to extract the greatest value from licensed portfolios. Ravi also advises clients on how the European Unitary Patent and the Unified Patent Court (UPC) affect their pending European applications and issued patents.
Notable Experience and Client Impact
- Advised a start-up company involved in cancer therapeutics and targeted drug delivery on the strategic development of their IP portfolio
- Developed a strategic plan for the IP portfolio of a pharmaceutical company involved in RNAi therapeutics
- Devised a patent portfolio directed to new anesthetics for a large hospital-based research organization; worked with the client and licensee to execute strategies that obtain the greatest value from the portfolio
- Developed two separate patent portfolios directed in the diagnostic space for a large hospital-based research organization; worked with the client and licensees to execute strategies that extract the greatest value from the portfolio
- Represented a university spinout developing novel therapeutic compositions for a range of clinical uses in patent prosecution and IP counseling
Prior to joining Nutter, Ravi was a partner in the patent practice group at a national law firm in Boston. He regularly writes and presents on patent issues in the life sciences industry.
Read More
Honors
Honors
- IAM Patent 1000, 2025
Education & Admissions
Education
Suffolk University Law School, J.D., cum laude
McGill University, Ph.D., Chemistry
University of Toronto, B.Sc., Biochemistry
Admissions
- Massachusetts
Industries
Noteworthy
- IAM Patent 1000, 2025
